Increased muscle quality and antioxidant capacity in hybrid sheep fed L-carnitine, suggesting benefits for meat production.
L-carnitine supplementation enhances fatty acid oxidation and antioxidant defense mechanisms in livestock. Twenty-four wether lambs were randomly assigned to one of three dietary treatments: a control (basal diet), a low-L-carnitine diet (0.01%), or a high-L-carnitine diet (0.05%). After a 15-day adaptation period, all lambs underwent a 45-day experimental phase to assess the impact of L-carnitine supplementation on performance, carcass, muscle, and antioxidant capacity. Although growth performance did not show significant differences (p > 0.05), muscle pH increased in the L-carnitine group (p < 0.05), while drip loss decreased in both the low- and high-dose groups (p < 0.05). The a* value of the Longissimus dorsi muscle significantly increased (p < 0.01), enhancing meat color saturation (p < 0.05), with a reduction in the hue angle observed in the high-dose group (p < 0.01). L-carnitine supplementation led to an elevated myoglobin content and a higher proportion of oxymyoglobin, driven by a significant increase in MRA activity (p < 0.01). The concentration of L-carnitine was positively correlated with the a* value, which in turn was associated with higher total myoglobin content and a greater proportion of oxymyoglobin. In terms of antioxidant capacity, the L-carnitine group exhibited a significant increase in superoxide dismutase content. Moreover, there was upregulation of TFR1 and CAT expression at the mRNA level, while HEPH showed downregulation (p < 0.01). Significant increases were observed in both content and mRNA expression of LDHB and NADHBR5 (p < 0.01). The addition of 0.05% L-carnitine to the diet significantly enhanced muscle color stability in hybrid sheep. This improvement was primarily driven by a significant increase in MRA activity in the high-dose group, which facilitated the conversion of metmyoglobin to oxymyoglobin, thereby significantly boosting meat quality prospects for the sheep industry.
No takes yet. Share an insight, caveat, or question.
Qin et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: